Creo Medical Group PLC (LON:CREO) insider Steve Morris acquired 115,325 shares of the company’s stock in a transaction dated Tuesday, January 9th. The shares were purchased at an average price of GBX 68 ($0.92) per share, for a total transaction of £78,421 ($106,347.98).
Shares of Creo Medical Group PLC (LON:CREO) opened at GBX 68 ($0.92) on Thursday. The stock has a market cap of $47.74 and a P/E ratio of -680.00. Creo Medical Group PLC has a 12 month low of GBX 67.02 ($0.91) and a 12 month high of GBX 110 ($1.49).
ILLEGAL ACTIVITY NOTICE: “Insider Buying: Creo Medical Group PLC (CREO) Insider Buys 115,325 Shares of Stock” was originally posted by Community Financial News and is the sole property of of Community Financial News. If you are viewing this piece of content on another website, it was stolen and republished in violation of U.S. and international trademark and copyright law. The original version of this piece of content can be viewed at https://www.com-unik.info/2018/01/11/insider-buying-creo-medical-group-plc-creo-insider-buys-115325-shares-of-stock.html.
About Creo Medical Group
Creo Medical Group plc is a United Kingdom-based medical device company. The Company focuses on the field of surgical endoscopy. The Company focuses on the development and commercialization of minimally invasive surgical devices, initially in the area of gastrointestinal (GI) surgery and lung cancer.
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.